Active Biotech Ab Stock Price To Earnings To Growth
| ACTI Stock | SEK 0.27 0.02 8.00% |
Active Biotech AB fundamentals help investors to digest information that contributes to Active Biotech's financial success or failures. It also enables traders to predict the movement of Active Stock. The fundamental analysis module provides a way to measure Active Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Active Biotech stock.
Active |
Active Biotech AB Company Price To Earnings To Growth Analysis
Active Biotech's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Active Biotech AB has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to earnings to growth for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Active Fundamentals
| Return On Equity | -1.44 | |||
| Return On Asset | -0.67 | |||
| Current Valuation | 224.92 M | |||
| Shares Outstanding | 264.89 M | |||
| Shares Owned By Insiders | 45.94 % | |||
| Shares Owned By Institutions | 15.84 % | |||
| Price To Earning | (8.47) X | |||
| Price To Book | 5.63 X | |||
| Price To Sales | 29.72 X | |||
| Gross Profit | 6.72 M | |||
| EBITDA | (48.52 M) | |||
| Net Income | (49.83 M) | |||
| Cash And Equivalents | 53.13 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 200 K | |||
| Debt To Equity | 268.10 % | |||
| Current Ratio | 1.37 X | |||
| Book Value Per Share | 0.13 X | |||
| Cash Flow From Operations | (46.17 M) | |||
| Earnings Per Share | (0.25) X | |||
| Target Price | 3.0 | |||
| Beta | 0.53 | |||
| Market Capitalization | 268.37 M | |||
| Total Asset | 56.8 M | |||
| Working Capital | 36 M | |||
| Current Asset | 65 M | |||
| Current Liabilities | 29 M | |||
| Net Asset | 56.8 M |
About Active Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Active Biotech AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Active Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Active Biotech AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Active Stock Analysis
When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.